NUMAB THERAPEUTICS
J&J acquires experimental skin disorder drug for $1.25 billionNUMAB THERAPEUTICS-JOHNSON&JOHNSON/M&A (UPDATE 2, PIX)UPDATE 2-J&J acquires experimental skin disorder drug for $1.25 billion
- Load More
Death toll in Venezuela quake tops 1,400 as rescue efforts intensify
UPSC Civil Services Main Exam 2026: Last day to file application today; check details
Iran's IRGC launches missile, drone strikes on US military sites in Kuwait, Bahrain
FIFA World Cup: Colombia and Portugal advance after no-bore draw in Miami
Sridhar Vembu on why Chennai and Bengaluru land prices rival New York
Georgia Homicide: Store manager, a mother of 3 fatally shot over $1.58 Purchase of hamburger buns
FIFA World Cup: Congo rallies to a 3-1 win against Uzbekistan to seal place in knockouts
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service